Ustekinumab-aekn — Point32Health
Plaque Psoriasis
Preferred products
- Yesintek
Initial criteria
- Documented diagnosis of plaque psoriasis
- Patient age ≥ 6 years
- Prescribed by or in consultation with a dermatologist
- Trial and failure of at least two of the listed medications from each of the following therapeutic categories (only one medication is required if only one is available for a listed therapeutic category): Interleukin Antagonists: Bimzelx, Skyrizi, Taltz, Tremfya; Phosphodiesterase 4 inhibitors: Otezla; Tumor Necrosis Factors: Cimzia, Enbrel, Humira OR Contraindication to all the following medications: Bimzelx, Skyrizi, Taltz, Tremfya, Otezla, Cimzia, Enbrel, and Humira
- Documented previous failure or clinical inappropriateness of treatment with Yesintek